<h3>Gainers</h3>
<ul>
<li>INVO Fertility (NASDAQ:IVF) stock increased by 280.3% to $3.09 during Tuesday's regular session. The company's market cap stands at $12.2 million. </li>
<li>Corvus Pharma (NASDAQ:CRVS) stock moved upwards by 97.76% to $15.92. The market value of their outstanding shares is at $601.1 million. </li>
<li>Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 69.93% to $2.77. The market value of their outstanding shares is at $2.6 million. </li>
<li>RAPT Therapeutics (NASDAQ:RAPT) shares increased by 63.86% to $57.52. The market value of their outstanding shares is at $972.6 million. </li>
<li>Aclaris Therapeutics (NASDAQ:ACRS) shares rose 41.79% to $3.71. The market value of their outstanding shares is at $283.8 million. </li>
<li>Rockwell Medical (NASDAQ:RMTI) shares rose 31.6% to $1.26. The company's market cap stands at $37.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NovaBay Pharmaceuticals (AMEX:NBY) stock decreased by 53.5% to $6.87 during Tuesday's regular session. The market value of their outstanding shares is at $1.8 billion. </li>
<li>Venus Concept (NASDAQ:VERO) stock declined by 41.57% to $4.67. The market value of their outstanding shares is at $14.8 million. </li>
<li>Jaguar Health (NASDAQ:JAGX) stock declined by 38.47% to $0.88. The company's market cap stands at $5.9 million. </li>
<li>Synlogic (NASDAQ:SYBX) shares decreased by 37.51% to $0.7. The market value of their outstanding shares is at $13.1 million. </li>
<li>NewGenIvf Group (NASDAQ:NIVF) stock fell 26.12% to $0.41. </li>
<li>Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock declined by 19.06% to $0.17. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In Tuesday's intraday session, several health care stocks experienced significant movements. INVO Fertility (IVF) surged by 280.3% to $3.09, while Corvus Pharma (CRVS) rose by 97.76% to $15.92. Other gainers included Shuttle Pharmaceuticals (SHPH) up 69.93%, RAPT Therapeutics (RAPT) up 63.86%, and Aclaris Therapeutics (ACRS) up 41.79%. Conversely, NovaBay Pharmaceuticals (NBY) fell by 53.5% to $6.87, followed by Venus Concept (VERO) down 41.57%, and Jaguar Health (JAGX) down 38.47%.

benzinga_article

Proshares Ultra Nasdaq Biotech

iShares US Pharma

VG Health

Invesco Nasdaq Biotechnology ETF

INVO Fertility

Jaguar Health

iShares US Healthcare Providers

SPDR S&P Health Equip

RAPT Therapeutics

SPDR S&P Biotech

VanEck Biotech ETF

Ark Genomic Revolution ETF

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

Aclaris Therap

Corvus Pharma

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

iShares Global Healthcare

Venus Concept

Novabay Pharmac

iShares Biotechnology ETF

SPDR S&P Health

Shuttle Pharmaceuticals

12 Health Care Stocks Moving In Tuesday's Intraday Session